Discovery
Scripps developing three-antigen nanoparticle platform for universal flu vaccine
Scripps Research Institute has received a USD 3.68 million NIAID R01 grant to develop a multicomponent self-assembling protein nanoparticle platform...
NIH backs Yale's non-viral CRISPR platform for neurological gene editing
Yale University has received a USD 3.5 million NIH supplement award to advance a non-viral CRISPR delivery platform toward a first-in-human Phase I safety...
Stanford researchers uncover blood-to-brain immune cell migration in human aging
Researchers at Stanford Medicine have identified a previously unrecognized phenomenon in which peripheral blood-derived immune cells migrate into the human...
Stanford researchers use Evo AI models to design novel bacteriophages against E. coli
Researchers at Stanford University have used a generative AI model to design functional bacteriophages entirely from scratch, demonstrating for the first...
Washington University wins NIA grant to study immune clearance in Alzheimer's disease
Note: The orglookupsummary returned a mismatched result (Western Washington University) that does not correspond to the funded institution, Washington...
University of Colorado renews work on CAR-phagocyte pediatric brain cancer therapy
The University of Colorado Cancer Center has received a USD 1.28 million NIH R01 renewal from the National Cancer Institute to develop chimeric antigen...
Albert Einstein to optimize RNA vaccine designs for pandemics with NIAID support
Albert Einstein College of Medicine has received a USD 2.09 million NIAID award to advance RNA vaccine design against emerging viral pathogens with pandemic...
University of Arizona gets NIAID backing for CD4+ T cell profiling platform
The University of Arizona has received a USD 3.19 million R01 grant from the National Institute of Allergy and Infectious Diseases to develop a novel assay...
USC wins NIA funding to advance first brain-penetrant cPLA2 inhibitors for Alzheimer's
University of Southern California has received a USD 1.67 million NIA U01 cooperative agreement to advance brain-penetrant small molecule inhibitors of...
Weill Cornell advances mitochondrial ROS inhibitors for Alzheimer's with NIA grant
Weill Cornell Medicine has received a USD 4.2 million RF1 grant from the National Institute on Aging (NIA) to advance preclinical development of a class of...
RevaGenix lands USD 12.1m NIAID contract to advance AMR therapeutics
San Mateo, California-based RevaGenix, Inc. has received a USD 12.1 million NIAID R&D contract to advance therapeutic candidates targeting antimicrobial...
University of Washington secures NIH funding for AI-guided islet cell engineering
University of Washington has received a USD 1.71 million NIDDK RC2 grant to develop AI-designed mini-proteins that epigenetically direct pluripotent stem...
UC Davis advances bacterial-made microRNA therapy with renewed NCI funding
University of California, Davis has received a USD 1.18 million National Cancer Institute R01 renewal to advance bioengineered microRNA therapeutics for...
UNC Charlotte spinout OncoTab wins grant to advance tMUC1 TCE for pancreatic cancer
OncoTab, a Charlotte, North Carolina-based biotechnology company, has received a USD 1.13 million National Cancer Institute R44 SBIR Phase II grant to...
Researchers harness pre-existing COVID-19 immunity to boost experimental cancer vaccine
Researchers at Case Western Reserve University and Cleveland-based Celloram Inc. have demonstrated that a dendritic cell cancer vaccine designed to co-opt...
The AllSci Brief
Free, systematic R&D and deal news. Daily.